Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke

PHASE4CompletedINTERVENTIONAL
Enrollment

622

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Ischemic Stroke
Interventions
DRUG

Qizhitongluo Capsule

DRUG

Naoxintong Capsule

DRUG

Aspirin Enteric-coated Tablets

BEHAVIORAL

the routine recovery training

DRUG

placebo

Trial Locations (13)

100700

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing

462000

Luohe Hospital of Chinese Medicine, Luohe

530023

The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning

610075

Teaching Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu

Unknown

Langfang TCM Hospital, Langfang

the First affiliated Hospital of Henan University of TCM, Zhengzhou

the affiliated Hospital to Changchun University of Chinese Medicine, Changchun

201 Hospital of People's Liberation Army, Dalian

Zhongshan Hospital Dalian University, Dalian

Second Hospital affiliated to Liaoning University of Traditional Chinese Medicine, Shenyang

West China Hospital,Sichuan University, Chengdu

Guang'anmen Hospital Nan District,China Academy of Chinese Medical Sciences, Beijing

First Teaching Hospital of Tianjin University of TCM, Tianjin

All Listed Sponsors
lead

China Academy of Chinese Medical Sciences

OTHER

NCT01762163 - Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke | Biotech Hunter | Biotech Hunter